(Reporting by Manas Mishra in Bengaluru; Editing by Arun Koyyur)
Biogen profit more than doubles on Samsung Bioepis stake sale
(Reuters) - Biogen Inc's second-quarter profit more than doubled on Wednesday, driven by a roughly $1.5-billion gain from the sale of its equity stake in the Samsung Bioepis Joint Venture.